25 XP   0   0   10

Precision BioSciences Inc
Buy, Hold or Sell?

Let's analyse Precision BioSciences Inc together

PenkeI guess you are interested in Precision BioSciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Precision BioSciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Precision BioSciences Inc

I send you an email if I find something interesting about Precision BioSciences Inc.

Quick analysis of Precision BioSciences Inc (30 sec.)










What can you expect buying and holding a share of Precision BioSciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.25
Expected worth in 1 year
$-0.26
How sure are you?
29.2%

+ What do you gain per year?

Total Gains per Share
$-0.51
Return On Investment
-3.9%

For what price can you sell your share?

Current Price per Share
$12.98
Expected price per share
$10.50 - $21.30
How sure are you?
50%

1. Valuation of Precision BioSciences Inc (5 min.)




Live pricePrice per Share (EOD)

$12.98

Intrinsic Value Per Share

$6.20 - $7.77

Total Value Per Share

$6.46 - $8.02

2. Growth of Precision BioSciences Inc (5 min.)




Is Precision BioSciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$29m$87m-$46.1m-112.7%

How much money is Precision BioSciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$20m-$27.1m$7.1m35.9%
Net Profit Margin-183.6%-603.7%--

How much money comes from the company's main activities?

3. Financial Health of Precision BioSciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#549 / 1031

Most Revenue
#265 / 1031

Most Profit
#731 / 1031

Most Efficient
#646 / 1031

What can you expect buying and holding a share of Precision BioSciences Inc? (5 min.)

Welcome investor! Precision BioSciences Inc's management wants to use your money to grow the business. In return you get a share of Precision BioSciences Inc.

What can you expect buying and holding a share of Precision BioSciences Inc?

First you should know what it really means to hold a share of Precision BioSciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Precision BioSciences Inc is $12.98. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Precision BioSciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Precision BioSciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.25. Based on the TTM, the Book Value Change Per Share is $-0.13 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Precision BioSciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.07-0.5%-0.16-1.3%-0.38-2.9%-0.40-3.1%-0.42-3.2%
Usd Book Value Change Per Share-0.05-0.4%-0.13-1.0%-0.23-1.8%0.050.4%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-0.4%-0.13-1.0%-0.23-1.8%0.050.4%0.010.1%
Usd Price Per Share0.34-0.70-3.35-6.65-5.54-
Price to Earnings Ratio-1.22--1.12--2.25--3.31--2.76-
Price-to-Total Gains Ratio-7.41--6.35--12.09-22.22-22.22-
Price to Book Ratio1.35-1.85-2.58-5.13-4.28-
Price-to-Total Gains Ratio-7.41--6.35--12.09-22.22-22.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share12.98
Number of shares77
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.130.05
Usd Total Gains Per Share-0.130.05
Gains per Quarter (77 shares)-9.803.99
Gains per Year (77 shares)-39.1815.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-39-490166
20-78-8803222
30-118-12704838
40-157-16606454
50-196-20508070
60-235-24409686
70-274-2830112102
80-313-3220128118
90-353-3610144134
100-392-4000160150

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.023.00.04.2%1.023.00.04.2%
Book Value Change Per Share0.04.00.00.0%4.08.00.033.3%6.014.00.030.0%7.015.02.029.2%7.015.02.029.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.024.00.0%0.00.024.00.0%
Total Gains per Share0.04.00.00.0%4.08.00.033.3%6.014.00.030.0%7.015.02.029.2%7.015.02.029.2%

Fundamentals of Precision BioSciences Inc

About Precision BioSciences Inc

Precision BioSciences, Inc., a clinical stage gene editing company, develops ex vivo allogeneic chimeric antigen receptor (CAR) T immunotherapies and in vivo therapies for genetic and infectious diseases in the United States. The company offers ARCUS, a genome editing platform to cure genetic disorders. It also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific type of immune cell is genetically engineered to recognize and kill cancer cells; PBCAR0191, an azercabtagene zapreleucel, for the treatment of acute lymphoblastic leukemia and B-cell precursor acute lymphoblastic leukemia; PBCAR19B, an anti-CD19 CAR T candidate built on the stealth cell platform utilizing a single-step gene edit to minimize the risk of chromosome abnormalities; and PBCAR269A, an investigational allogeneic CAR T cell candidate targeting B-cell maturation antigen for relapsed or refractory (R/R) multiple myeloma in combination with nirogacestat, a gamma secretase inhibitor. The company has development and commercial license agreements with Les Laboratoires Servier to develop allogeneic CAR T cell therapies for antigen targets, hematological cancer targets beyond CD19, and solid tumor targets; Tiziana Life Sciences to evaluate foralumab, a fully human anti-CD3 monoclonal antibody as a lymphodepleting agent for the potential treatment of cancers; iECURE, Inc. to develop ARCUS-based gene-insertion therapies; and Novartis Pharma AG to discover and develop in vivo gene editing products. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.

Fundamental data was last updated by Penke on 2024-03-20 15:37:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Precision BioSciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Precision BioSciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Precision BioSciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -61.6% means that $-0.62 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Precision BioSciences Inc:

  • The MRQ is -61.6%. The company is making a huge loss. -2
  • The TTM is -183.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-61.6%TTM-183.6%+122.0%
TTM-183.6%YOY-603.7%+420.1%
TTM-183.6%5Y-465.8%+282.2%
5Y-465.8%10Y-475.2%+9.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-61.6%-171.8%+110.2%
TTM-183.6%-205.8%+22.2%
YOY-603.7%-262.1%-341.6%
5Y-465.8%-455.6%-10.2%
10Y-475.2%-589.0%+113.8%
1.1.2. Return on Assets

Shows how efficient Precision BioSciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Precision BioSciences Inc to the Biotechnology industry mean.
  • -4.9% Return on Assets means that Precision BioSciences Inc generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Precision BioSciences Inc:

  • The MRQ is -4.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.9%TTM-9.6%+4.7%
TTM-9.6%YOY-11.7%+2.1%
TTM-9.6%5Y-10.2%+0.6%
5Y-10.2%10Y-10.6%+0.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.9%-12.5%+7.6%
TTM-9.6%-12.2%+2.6%
YOY-11.7%-11.2%-0.5%
5Y-10.2%-13.4%+3.2%
10Y-10.6%-14.7%+4.1%
1.1.3. Return on Equity

Shows how efficient Precision BioSciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Precision BioSciences Inc to the Biotechnology industry mean.
  • -27.8% Return on Equity means Precision BioSciences Inc generated $-0.28 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Precision BioSciences Inc:

  • The MRQ is -27.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -45.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.8%TTM-45.4%+17.6%
TTM-45.4%YOY-31.8%-13.6%
TTM-45.4%5Y-42.9%-2.6%
5Y-42.9%10Y-35.7%-7.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.8%-15.8%-12.0%
TTM-45.4%-15.7%-29.7%
YOY-31.8%-13.9%-17.9%
5Y-42.9%-18.3%-24.6%
10Y-35.7%-19.2%-16.5%

1.2. Operating Efficiency of Precision BioSciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Precision BioSciences Inc is operating .

  • Measures how much profit Precision BioSciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Precision BioSciences Inc to the Biotechnology industry mean.
  • An Operating Margin of -94.2% means the company generated $-0.94  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Precision BioSciences Inc:

  • The MRQ is -94.2%. The company is operating very inefficient. -2
  • The TTM is -159.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-94.2%TTM-159.1%+64.9%
TTM-159.1%YOY-598.0%+438.9%
TTM-159.1%5Y-461.6%+302.5%
5Y-461.6%10Y-472.0%+10.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-94.2%-299.1%+204.9%
TTM-159.1%-210.1%+51.0%
YOY-598.0%-279.7%-318.3%
5Y-461.6%-459.9%-1.7%
10Y-472.0%-596.9%+124.9%
1.2.2. Operating Ratio

Measures how efficient Precision BioSciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.10 means that the operating costs are $2.10 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Precision BioSciences Inc:

  • The MRQ is 2.097. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.756. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.097TTM2.756-0.658
TTM2.756YOY7.066-4.310
TTM2.7565Y5.614-2.858
5Y5.61410Y5.743-0.129
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0972.861-0.764
TTM2.7563.193-0.437
YOY7.0663.615+3.451
5Y5.6145.560+0.054
10Y5.7437.396-1.653

1.3. Liquidity of Precision BioSciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Precision BioSciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.88 means the company has $2.88 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Precision BioSciences Inc:

  • The MRQ is 2.881. The company is able to pay all its short-term debts. +1
  • The TTM is 3.112. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.881TTM3.112-0.230
TTM3.112YOY4.345-1.233
TTM3.1125Y5.073-1.961
5Y5.07310Y4.518+0.554
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8813.986-1.105
TTM3.1124.440-1.328
YOY4.3455.552-1.207
5Y5.0736.158-1.085
10Y4.5186.492-1.974
1.3.2. Quick Ratio

Measures if Precision BioSciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Precision BioSciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 2.48 means the company can pay off $2.48 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Precision BioSciences Inc:

  • The MRQ is 2.484. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.875. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.484TTM2.875-0.391
TTM2.875YOY3.962-1.087
TTM2.8755Y4.710-1.835
5Y4.71010Y3.925+0.785
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4843.638-1.154
TTM2.8754.168-1.293
YOY3.9625.515-1.553
5Y4.7106.012-1.302
10Y3.9256.209-2.284

1.4. Solvency of Precision BioSciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Precision BioSciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Precision BioSciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.82 means that Precision BioSciences Inc assets are financed with 82.3% credit (debt) and the remaining percentage (100% - 82.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Precision BioSciences Inc:

  • The MRQ is 0.823. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.796. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.823TTM0.796+0.027
TTM0.796YOY0.632+0.164
TTM0.7965Y0.638+0.159
5Y0.63810Y0.758-0.121
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8230.335+0.488
TTM0.7960.330+0.466
YOY0.6320.267+0.365
5Y0.6380.367+0.271
10Y0.7580.378+0.380
1.4.2. Debt to Equity Ratio

Measures if Precision BioSciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Precision BioSciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 465.5% means that company has $4.65 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Precision BioSciences Inc:

  • The MRQ is 4.655. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.006. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.655TTM4.006+0.649
TTM4.006YOY1.757+2.249
TTM4.0065Y2.694+1.312
5Y2.69410Y2.245+0.449
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6550.376+4.279
TTM4.0060.398+3.608
YOY1.7570.334+1.423
5Y2.6940.429+2.265
10Y2.2450.476+1.769

2. Market Valuation of Precision BioSciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Precision BioSciences Inc generates.

  • Above 15 is considered overpriced but always compare Precision BioSciences Inc to the Biotechnology industry mean.
  • A PE ratio of -1.22 means the investor is paying $-1.22 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Precision BioSciences Inc:

  • The EOD is -46.261. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.215. Based on the earnings, the company is expensive. -2
  • The TTM is -1.118. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-46.261MRQ-1.215-45.046
MRQ-1.215TTM-1.118-0.097
TTM-1.118YOY-2.250+1.132
TTM-1.1185Y-3.314+2.196
5Y-3.31410Y-2.762-0.552
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-46.261-2.643-43.618
MRQ-1.215-2.418+1.203
TTM-1.118-2.742+1.624
YOY-2.250-4.123+1.873
5Y-3.314-6.257+2.943
10Y-2.762-6.478+3.716
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Precision BioSciences Inc:

  • The EOD is -15.884. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.417. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.803. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.884MRQ-0.417-15.467
MRQ-0.417TTM-0.803+0.386
TTM-0.803YOY-1.442+0.639
TTM-0.8035Y-2.937+2.134
5Y-2.93710Y-2.447-0.489
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-15.884-3.244-12.640
MRQ-0.417-2.939+2.522
TTM-0.803-3.478+2.675
YOY-1.442-5.592+4.150
5Y-2.937-8.473+5.536
10Y-2.447-8.881+6.434
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Precision BioSciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.35 means the investor is paying $1.35 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Precision BioSciences Inc:

  • The EOD is 51.439. Based on the equity, the company is expensive. -2
  • The MRQ is 1.351. Based on the equity, the company is underpriced. +1
  • The TTM is 1.847. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD51.439MRQ1.351+50.088
MRQ1.351TTM1.847-0.496
TTM1.847YOY2.576-0.729
TTM1.8475Y5.133-3.286
5Y5.13310Y4.278+0.856
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD51.4392.124+49.315
MRQ1.3512.041-0.690
TTM1.8472.118-0.271
YOY2.5762.915-0.339
5Y5.1333.682+1.451
10Y4.2784.114+0.164
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Precision BioSciences Inc.

3.1. Institutions holding Precision BioSciences Inc

Institutions are holding 37.399% of the shares of Precision BioSciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Capital World Investors4.1990.00035119458-1595585-23.7614
2023-09-30Vanguard Group Inc3.849304693076-24292-0.5149
2023-12-31Acadian Asset Management LLC2.74270.004733439141956716.2152
2023-09-30Citadel Advisors Llc2.57050.0002313390942188215.556
2023-12-31Renaissance Technologies Corp2.12530.0015259121299913862.757
2023-12-31Stifel Financial Corp1.26790.00071545850220111.4444
2023-09-30Jacobs Levy Equity Management, Inc.1.16840.0029142453564383982.4699
2023-09-30UBS O'Connor LLC1.09770.0086133829500
2023-09-30OUP Management Co., LLC0.92180.8627112391300
2023-12-31BlackRock Inc0.91780111896700
2023-12-31Geode Capital Management, LLC0.734408954158257610.159
2023-12-31Moloney Securities Asset Management0.73020.051689025024875038.7763
2023-12-31Tejara Capital Ltd0.60940.113674301434440086.3994
2023-09-30Bank of America Corp0.552306733886376141782.3391
2023-09-30CHI Advisors LLC0.49760.0821606629-996928-62.1698
2023-09-30Goldman Sachs Group Inc0.38880474066308342186.0575
2023-09-30Jacob Asset Mgmt Of NY LLC0.32020.187939041200
2023-12-31Curi Wealth Management, LLC0.27890.01723400212200.0647
2023-12-31Morgan Stanley - Brokerage Accounts0.2741033414910424345.3416
2023-09-30Millennium Management LLC0.24090.0001293662127864.5522
Total 25.48721.334131074135+1404667+4.5%

3.2. Funds holding Precision BioSciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31American Funds SMALLCAP World A4.1990.00265119458-1595585-23.7614
2024-01-31Vanguard Total Stock Mkt Idx Inv1.99880.0001243696000
2024-01-31Vanguard Institutional Extnd Mkt Idx Tr0.74930.000491358300
2023-12-31Fidelity Extended Market Index0.41160.00055018009180622.392
2023-12-31Vanguard Strategic Small-Cap Equity Inv0.41060.012350066000
2023-12-31Vanguard VIF Small Co Gr0.37910.011246217200
2023-07-31Galileo - Biotech Innovation Fund S USD0.35790.707443631700
2023-12-31Vanguard Explorer Inv0.28080.000634230100
2023-12-31Jacob Discovery Fd Instl0.25240.55533077005000019.4024
2023-12-31Jacob Small Cap Growth Investor0.23351.3155284712152000114.5337
2023-12-31SG Actions US Techno C0.20970.016725563600
2023-09-30Bridgeway Ultra-Small Company Market0.18330.045422350000
2023-09-30BlackRock Extended Mkt Composite0.16740.000520403400
2023-12-31BlackRock Extended Equity Market K0.1460.0005178003-359-0.2013
2023-12-31Fidelity Total Market Index0.12450.000115173600
2023-12-31Fidelity Series Total Market Index0.09590.000111692000
2023-12-31Harbor Disruptive Innovation Instl0.08420.051410270980818.5398
2024-01-31Vanguard Balanced Index Inv0.08130.00019910000
2023-12-31NT Ext Equity Mkt Idx Fd - L0.06810.00058305600
2023-12-31Northern Trust Extended Eq Market Idx0.06810.00058305600
Total 10.50152.721712803413-1294057-10.1%

3.3. Insider Transactions

Insiders are holding 9.226% of the shares of Precision BioSciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-22Alan ListSELL71710.8
2024-01-22Dario ScimecaSELL70910.8
2024-01-22Michael AmorosoSELL457910.8
2023-11-03Dario ScimecaSELL53412
2023-11-03Michael AmorosoSELL416712
2023-04-27Alan ListSELL25923.7
2023-03-22Michael AmorosoSELL156624.6

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Precision BioSciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.046-0.127+177%-0.235+410%0.052-189%0.011-538%
Book Value Per Share--0.2520.364-31%1.237-80%1.395-82%0.897-72%
Current Ratio--2.8813.112-7%4.345-34%5.073-43%4.518-36%
Debt To Asset Ratio--0.8230.796+3%0.632+30%0.638+29%0.758+9%
Debt To Equity Ratio--4.6554.006+16%1.757+165%2.694+73%2.245+107%
Dividend Per Share----0%-0%-0%-0%
Eps---0.070-0.164+134%-0.377+437%-0.404+476%-0.421+500%
Free Cash Flow Per Share---0.204-0.223+9%-0.256+25%-0.356+74%-0.403+97%
Free Cash Flow To Equity Per Share---0.205-0.217+6%0.130-257%0.029-795%0.054-481%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--7.767--------
Intrinsic Value_10Y_min--6.204--------
Intrinsic Value_1Y_max---0.455--------
Intrinsic Value_1Y_min---0.447--------
Intrinsic Value_3Y_max---0.426--------
Intrinsic Value_3Y_min---0.426--------
Intrinsic Value_5Y_max--0.735--------
Intrinsic Value_5Y_min--0.601--------
Market Cap85200200.800+54%39274590.43278812913.983-50%220569033.100-82%340457745.011-88%283714787.509-86%
Net Profit Margin---0.616-1.836+198%-6.037+880%-4.658+656%-4.752+672%
Operating Margin---0.942-1.591+69%-5.980+535%-4.616+390%-4.720+401%
Operating Ratio--2.0972.756-24%7.066-70%5.614-63%5.743-63%
Pb Ratio51.439+97%1.3511.847-27%2.576-48%5.133-74%4.278-68%
Pe Ratio-46.261-3706%-1.215-1.118-8%-2.250+85%-3.314+173%-2.762+127%
Price Per Share12.980+97%0.3410.703-51%3.345-90%6.647-95%5.539-94%
Price To Free Cash Flow Ratio-15.884-3706%-0.417-0.803+92%-1.442+246%-2.937+604%-2.447+486%
Price To Total Gains Ratio-282.135-3706%-7.412-6.353-14%-12.095+63%22.222-133%22.222-133%
Quick Ratio--2.4842.875-14%3.962-37%4.710-47%3.925-37%
Return On Assets---0.049-0.096+95%-0.117+137%-0.102+107%-0.106+116%
Return On Equity---0.278-0.454+63%-0.318+14%-0.429+54%-0.357+28%
Total Gains Per Share---0.046-0.127+177%-0.235+410%0.052-189%0.011-538%
Usd Book Value--29063000.00040928500.000-29%87057500.000-67%80025700.000-64%62293250.000-53%
Usd Book Value Change Per Share---0.046-0.127+177%-0.235+410%0.052-189%0.011-538%
Usd Book Value Per Share--0.2520.364-31%1.237-80%1.395-82%0.897-72%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.070-0.164+134%-0.377+437%-0.404+476%-0.421+500%
Usd Free Cash Flow---23529000.000-25112250.000+7%-12945750.000-45%-17729150.000-25%-16968958.333-28%
Usd Free Cash Flow Per Share---0.204-0.223+9%-0.256+25%-0.356+74%-0.403+97%
Usd Free Cash Flow To Equity Per Share---0.205-0.217+6%0.130-257%0.029-795%0.054-481%
Usd Market Cap85200200.800+54%39274590.43278812913.983-50%220569033.100-82%340457745.011-88%283714787.509-86%
Usd Price Per Share12.980+97%0.3410.703-51%3.345-90%6.647-95%5.539-94%
Usd Profit---8079000.000-20003750.000+148%-27177750.000+236%-20718200.000+156%-18847500.000+133%
Usd Revenue--13120000.00013071750.000+0%5209750.000+152%11688950.000+12%10051916.667+31%
Usd Total Gains Per Share---0.046-0.127+177%-0.235+410%0.052-189%0.011-538%
 EOD+5 -3MRQTTM+21 -12YOY+18 -155Y+13 -2010Y+13 -20

4.2. Fundamental Score

Let's check the fundamental score of Precision BioSciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-46.261
Price to Book Ratio (EOD)Between0-151.439
Net Profit Margin (MRQ)Greater than0-0.616
Operating Margin (MRQ)Greater than0-0.942
Quick Ratio (MRQ)Greater than12.484
Current Ratio (MRQ)Greater than12.881
Debt to Asset Ratio (MRQ)Less than10.823
Debt to Equity Ratio (MRQ)Less than14.655
Return on Equity (MRQ)Greater than0.15-0.278
Return on Assets (MRQ)Greater than0.05-0.049
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Precision BioSciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.433
Ma 20Greater thanMa 5012.376
Ma 50Greater thanMa 10012.230
Ma 100Greater thanMa 20011.979
OpenGreater thanClose12.800
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets164,344
Total Liabilities135,281
Total Stockholder Equity29,063
 As reported
Total Liabilities 135,281
Total Stockholder Equity+ 29,063
Total Assets = 164,344

Assets

Total Assets164,344
Total Current Assets145,852
Long-term Assets18,492
Total Current Assets
Cash And Cash Equivalents 122,231
Net Receivables 3,510
Other Current Assets 20,111
Total Current Assets  (as reported)145,852
Total Current Assets  (calculated)145,852
+/-0
Long-term Assets
Property Plant Equipment 9,815
Long Term Investments 1,807
Intangible Assets 977
Long-term Assets Other 5,893
Long-term Assets  (as reported)18,492
Long-term Assets  (calculated)18,492
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities50,617
Long-term Liabilities84,664
Total Stockholder Equity29,063
Total Current Liabilities
Short-term Debt 1,494
Short Long Term Debt 22,365
Accounts payable 531
Other Current Liabilities 31,147
Total Current Liabilities  (as reported)50,617
Total Current Liabilities  (calculated)55,537
+/- 4,920
Long-term Liabilities
Capital Lease Obligations 1,494
Long-term Liabilities Other 766
Long-term Liabilities  (as reported)84,664
Long-term Liabilities  (calculated)2,260
+/- 82,404
Total Stockholder Equity
Common Stock1
Retained Earnings -473,342
Other Stockholders Equity 502,404
Total Stockholder Equity (as reported)29,063
Total Stockholder Equity (calculated)29,063
+/-0
Other
Capital Stock1
Cash and Short Term Investments 122,231
Common Stock Shares Outstanding 115,175
Current Deferred Revenue17,445
Liabilities and Stockholders Equity 164,344
Net Debt -120,737
Net Invested Capital 51,428
Net Working Capital 95,235
Property Plant and Equipment Gross 9,815
Short Long Term Debt Total 1,494



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
> Total Assets 
72,682
0
0
0
138,600
166,801
271,920
260,298
235,233
214,202
184,192
168,687
150,158
262,316
230,114
227,199
211,498
181,351
297,163
271,733
238,169
204,502
181,697
164,344
164,344181,697204,502238,169271,733297,163181,351211,498227,199230,114262,316150,158168,687184,192214,202235,233260,298271,920166,801138,60000072,682
   > Total Current Assets 
64,331
0
0
0
115,675
136,980
237,088
219,501
193,672
166,841
137,393
122,560
105,564
219,139
188,304
183,048
161,754
134,053
247,692
225,365
199,105
169,017
147,864
145,852
145,852147,864169,017199,105225,365247,692134,053161,754183,048188,304219,139105,564122,560137,393166,841193,672219,501237,088136,980115,67500064,331
       Cash And Cash Equivalents 
62,802
0
0
0
103,193
116,499
226,099
206,265
180,886
154,187
126,886
104,148
89,798
193,460
173,943
160,471
143,663
116,222
184,135
212,051
189,576
158,132
137,794
122,231
122,231137,794158,132189,576212,051184,135116,222143,663160,471173,943193,46089,798104,148126,886154,187180,886206,265226,099116,499103,19300062,802
       Net Receivables 
22
0
0
0
1,027
6,157
250
250
965
3,858
83
10,116
10,000
19,263
488
488
488
488
50,507
715
720
694
652
3,510
3,51065269472071550,50748848848848819,26310,00010,116833,8589652502506,1571,02700022
       Other Current Assets 
70
0
0
0
11,455
6,025
2,474
2,248
2,324
934
240
61
4
35
5,416
898
169
283
418
307
1,257
1,767
503
20,111
20,1115031,7671,2573074182831698985,416354612409342,3242,2482,4746,02511,45500070
   > Long-term Assets 
0
0
0
0
22,925
29,821
34,832
40,797
41,561
47,361
46,799
46,127
44,594
43,177
41,810
44,151
49,744
47,298
49,471
46,368
39,064
35,485
33,833
18,492
18,49233,83335,48539,06446,36849,47147,29849,74444,15141,81043,17744,59446,12746,79947,36141,56140,79734,83229,82122,9250000
       Property Plant Equipment 
8,137
0
0
0
21,147
27,908
32,962
38,959
39,571
45,372
44,036
43,185
41,500
40,007
38,602
37,049
29,334
27,766
26,648
25,080
23,164
21,240
22,970
9,815
9,81522,97021,24023,16425,08026,64827,76629,33437,04938,60240,00741,50043,18544,03645,37239,57138,95932,96227,90821,1470008,137
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
812
10,630
9,765
4,442
6,711
9,406
8,159
1,807
1,807
1,8071,8078,1599,4066,7114,4429,76510,630812000000000000000
       Intangible Assets 
90
0
0
0
1,466
1,460
1,453
1,446
1,432
1,417
1,402
1,387
1,373
1,358
1,343
2,074
2,048
2,021
1,995
1,969
1,348
1,525
1,552
977
9771,5521,5251,3481,9691,9952,0212,0482,0741,3431,3581,3731,3871,4021,4171,4321,4461,4531,4601,46600090
       Long-term Assets Other 
0
0
0
0
312
453
417
392
558
572
1,361
1,555
1,721
1,812
1,865
4,216
4,641
11,621
16,386
16,228
9,804
10,082
619
5,893
5,89361910,0829,80416,22816,38611,6214,6414,2161,8651,8121,7211,5551,3615725583924174533120000
> Total Liabilities 
99,051
0
0
0
98,640
155,971
97,942
104,510
96,919
99,168
98,593
104,863
105,733
203,494
129,561
125,756
120,330
111,692
194,140
187,353
177,736
164,325
147,656
135,281
135,281147,656164,325177,736187,353194,140111,692120,330125,756129,561203,494105,733104,86398,59399,16896,919104,51097,942155,97198,64000099,051
   > Total Current Liabilities 
9,203
0
0
0
14,075
71,384
15,820
23,726
26,932
23,757
34,311
41,983
42,829
63,797
36,251
36,475
35,980
29,106
53,923
61,148
59,664
46,859
56,399
50,617
50,61756,39946,85959,66461,14853,92329,10635,98036,47536,25163,79742,82941,98334,31123,75726,93223,72615,82071,38414,0750009,203
       Short-term Debt 
0
0
0
0
3,251
52,440
5,364
0
6,825
1,729
1,800
1,873
1,933
1,996
4,491
4,577
1,822
1,874
1,927
1,981
2,037
2,094
24,816
1,494
1,49424,8162,0942,0371,9811,9271,8741,8224,5774,4911,9961,9331,8731,8001,7296,82505,36452,4403,2510000
       Short Long Term Debt 
0
0
0
0
0
52,440
0
0
0
0
0
0
0
0
2,431
2,454
0
0
0
0
0
0
22,317
22,365
22,36522,3170000002,4542,4310000000052,44000000
       Accounts payable 
1,806
0
0
0
2,218
5,057
2,882
4,465
2,037
1,766
1,587
959
792
445
478
486
1,144
699
797
1,061
1,225
701
781
531
5317817011,2251,0617976991,1444864784457929591,5871,7662,0374,4652,8825,0572,2180001,806
       Other Current Liabilities 
5,891
0
0
0
170
4,416
445
8,494
1,584
6,955
7,864
9,932
9,868
8,262
9,061
9,436
11,770
6,847
9,685
9,701
10,210
5,796
6,991
31,147
31,1476,9915,79610,2109,7019,6856,84711,7709,4369,0618,2629,8689,9327,8646,9551,5848,4944454,4161700005,891
   > Long-term Liabilities 
0
0
0
0
84,565
84,587
82,122
80,784
69,987
75,411
64,282
62,880
62,904
139,697
93,310
89,281
84,350
82,586
140,217
126,205
118,072
117,466
91,257
84,664
84,66491,257117,466118,072126,205140,21782,58684,35089,28193,310139,69762,90462,88064,28275,41169,98780,78482,12284,58784,5650000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,478
2,482
22,119
22,173
22,223
22,270
0
0
0022,27022,22322,17322,1192,4822,4780000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-3,251
-52,440
-5,364
0
-6,825
9,476
9,121
9,091
8,586
8,062
5,091
4,512
4,813
4,327
3,823
3,305
2,776
2,233
-19,144
0
0-19,1442,2332,7763,3053,8234,3274,8134,5125,0918,0628,5869,0919,1219,476-6,8250-5,364-52,440-3,2510000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
392
139,697
487
89,281
81,872
80,104
227
104,032
95,849
95,196
0
766
766095,19695,849104,03222780,10481,87289,281487139,697392000000000000
> Total Stockholder Equity
-26,372
-26,372
0
0
39,960
10,830
173,978
155,788
138,314
115,034
85,599
63,824
44,425
58,822
100,553
101,443
91,168
69,659
103,023
84,380
60,433
40,177
34,041
29,063
29,06334,04140,17760,43384,380103,02369,65991,168101,443100,55358,82244,42563,82485,599115,034138,314155,788173,97810,83039,96000-26,372-26,372
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
111110000000000000000000
   Retained Earnings -473,342-465,263-453,372-428,312-399,824-375,878-344,843-316,675-294,385-283,106-304,762-286,073-262,620-236,604-203,903-177,067-156,151-135,409-115,973-85,187000-39,111
   Capital Surplus 
0
0
0
0
126,094
127,750
310,339
312,891
316,333
319,889
0
0
331,450
364,536
384,611
396,780
408,795
415,454
479,853
485,155
489,696
494,500
0
0
00494,500489,696485,155479,853415,454408,795396,780384,611364,536331,45000319,889316,333312,891310,339127,750126,0940000
   Treasury Stock00-952-952-952-952-952-952-952-952-952-95200-952-952-952-952-952-9520000
   Other Stockholders Equity 
0
0
0
0
130,631
126,798
309,387
311,939
326,030
318,937
322,203
326,444
330,498
363,584
383,659
395,828
407,843
414,502
478,901
484,203
488,744
493,548
499,303
502,404
502,404499,303493,548488,744484,203478,901414,502407,843395,828383,659363,584330,498326,444322,203318,937326,030311,939309,387126,798130,6310000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue52,287
Cost of Revenue--
Gross Profit-52,287
 
Operating Income (+$)
Gross Profit-
Operating Expense-131,300
Operating Income-79,013-131,300
 
Operating Expense (+$)
Research Development90,486
Selling General Administrative40,814
Selling And Marketing Expenses-
Operating Expense131,300131,300
 
Net Interest Income (+$)
Interest Income7,796
Interest Expense-2,137
Other Finance Cost-0
Net Interest Income5,659
 
Pretax Income (+$)
Operating Income-79,013
Net Interest Income5,659
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-87,248-65,119
EBIT - interestExpense = -2,137
-73,518
-71,381
Interest Expense2,137
Earnings Before Interest and Taxes (EBIT)--85,111
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-87,248
Tax Provision--
Net Income From Continuing Ops-87,248-87,248
Net Income-73,518
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-13,894-5,659
 

Technical Analysis of Precision BioSciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Precision BioSciences Inc. The general trend of Precision BioSciences Inc is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Precision BioSciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Precision BioSciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 19.43 < 20.46 < 21.30.

The bearish price targets are: 10.89 > 10.80 > 10.50.

Tweet this
Precision BioSciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Precision BioSciences Inc. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Precision BioSciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Precision BioSciences Inc. The current macd is -0.10714126.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Precision BioSciences Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Precision BioSciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Precision BioSciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Precision BioSciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartPrecision BioSciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Precision BioSciences Inc. The current adx is 13.95.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Precision BioSciences Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Precision BioSciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Precision BioSciences Inc. The current sar is 14.95.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Precision BioSciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Precision BioSciences Inc. The current rsi is 54.43. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Precision BioSciences Inc Daily Relative Strength Index (RSI) ChartPrecision BioSciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Precision BioSciences Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Precision BioSciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Precision BioSciences Inc Daily Stochastic Oscillator ChartPrecision BioSciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Precision BioSciences Inc. The current cci is 19.22.

Precision BioSciences Inc Daily Commodity Channel Index (CCI) ChartPrecision BioSciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Precision BioSciences Inc. The current cmo is 17.26.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Precision BioSciences Inc Daily Chande Momentum Oscillator (CMO) ChartPrecision BioSciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Precision BioSciences Inc. The current willr is -18.03921569.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Precision BioSciences Inc Daily Williams %R ChartPrecision BioSciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Precision BioSciences Inc.

Precision BioSciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Precision BioSciences Inc. The current atr is 1.02673942.

Precision BioSciences Inc Daily Average True Range (ATR) ChartPrecision BioSciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Precision BioSciences Inc. The current obv is -299,995.

Precision BioSciences Inc Daily On-Balance Volume (OBV) ChartPrecision BioSciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Precision BioSciences Inc. The current mfi is 44.73.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Precision BioSciences Inc Daily Money Flow Index (MFI) ChartPrecision BioSciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Precision BioSciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Precision BioSciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Precision BioSciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.433
Ma 20Greater thanMa 5012.376
Ma 50Greater thanMa 10012.230
Ma 100Greater thanMa 20011.979
OpenGreater thanClose12.800
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Precision BioSciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Precision BioSciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Precision BioSciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Precision BioSciences Inc

I send you an email if I find something interesting about Precision BioSciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Precision BioSciences Inc.

Receive notifications about Precision BioSciences Inc in your mailbox!